Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00014248 · ClinicalTrials.gov registry record · Phase 1
Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors
A Phase 1 study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00014248: Completed Phase 1 study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT00014248 is a Phase 1 study that has completed, run by Dartmouth-Hitchcock Medical Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00014248, a Phase 1 study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Adenosine triphosphate may decrease weight loss and improve muscle strength in patients with advanced solid tumors. PURPOSE: Phase I trial to study the effectiveness of adenosine triphosphate in controlling loss of weight and loss of muscle mass in patients who have advanced solid tumors.
Interventions
- PROCEDURE quality-of-life assessment
- DRUG adenosine triphosphate
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-10 |
| Phase | Phase 1 |
What the finished NCT00014248 record still lists
NCT00014248 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which quality-of-life assessment is the first listed.
NCT00014248 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00014248 about?
NCT00014248 is a clinical study titled "Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors". RATIONALE: Adenosine triphosphate may decrease weight loss and improve muscle strength in patients with advanced solid tumors. PURPOSE: Phase I trial to study the effectiveness of adenosine triphosphate in controlling loss of weight and loss of muscle mass in patients who have advanced solid tumors...
What is the current status of trial NCT00014248?
This trial is currently completed. It is a Phase 1 study. The study started on 2000-10.
What interventions are being tested in trial NCT00014248?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), adenosine triphosphate (DRUG).
Who is sponsoring clinical trial NCT00014248?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia